Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Diseases

Explore clinical trials studying Biliary Tract Diseases. Study availability and eligibility vary by location and protocol.

1,498 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Diseases trial results

Active, Not Recruiting

Linerixibat Long-term Safety, and Tolerability Study

NCT04167358

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site West Hollywood, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Detroit, Michigan, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

NCT04068194

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.

NCT05627362

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +3 more
Locations
  • Om Research LLC Lancaster, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • Sutter Health Van Ness Campus Medical Office Building San Francisco, California, United States
View all 62 locations
View Trial Details

Related conditions